BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moiseev S, Bossuyt X, Arimura Y, Blockmans D, Csernok E, Damoiseaux J, Emmi G, Flores-Suárez LF, Hellmich B, Jayne D, Jennette JC, Little MA, Mohammad AJ, Moosig F, Novikov P, Pagnoux C, Radice A, Sada KE, Segelmark M, Shoenfeld Y, Sinico RA, Specks U, Terrier B, Tzioufas AG, Vaglio A, Zhao MH, Cohen Tervaert JW; European EGPA Study Group. International Consensus on ANCA Testing in Eosinophilic Granulomatosis with Polyangiitis. Am J Respir Crit Care Med 2020. [PMID: 32584187 DOI: 10.1164/rccm.202005-1628SO] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Takeuchi H, Kawamura K, Kawasaki T, Oka N. Distinct features of hypereosinophilic syndrome with neuropathy from eosinophilic granulomatosis with polyangiitis. Front Neurol 2022;13. [DOI: 10.3389/fneur.2022.1057767] [Reference Citation Analysis]
2 Schindler V, Venhoff N. Eosinophile Granulomatose mit Polyangiitis – ein Übersichtsartikel. Aktuelle Rheumatologie 2022. [DOI: 10.1055/a-1947-5254] [Reference Citation Analysis]
3 Villa-forte A. Eosinophilic Granulomatosis with Polyangiitis. Postgraduate Medicine 2022. [DOI: 10.1080/00325481.2022.2134624] [Reference Citation Analysis]
4 Trivioli G, Marquez A, Martorana D, Tesi M, Kronbichler A, Lyons PA, Vaglio A. Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management. Nat Rev Rheumatol. [DOI: 10.1038/s41584-022-00819-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Liu S, Han L, Liu Y, Yang J, Zhang Y, Li M, Tian X, Zeng X, Wang L, Zhang F. Clinical Significance of MPO-ANCA in Eosinophilic Granulomatosis With Polyangiitis: Experience From a Longitudinal Chinese Cohort. Front Immunol 2022;13:885198. [DOI: 10.3389/fimmu.2022.885198] [Reference Citation Analysis]
6 Niccolai E, Bettiol A, Baldi S, Silvestri E, Di Gloria L, Bello F, Nannini G, Ricci F, Nicastro M, Ramazzotti M, Vaglio A, Bartolucci G, Emmi G, Amedei A, Prisco D. Gut Microbiota and Associated Mucosal Immune Response in Eosinophilic Granulomatosis with Polyangiitis (EGPA). Biomedicines 2022;10:1227. [DOI: 10.3390/biomedicines10061227] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Egan AC, Kronbichler A, Neumann I, Bettiol A, Carlson N, Cid MC, Emmi G, Gopaluni S, Harper L, Hauser T, Little MA, Luqmani RA, Mahr A, Mcclure M, Mohammad AJ, Nelveg-kristensen KE, Ohlsson S, Peh CA, Rutherford M, Sanchez Alamo B, Scott J, Segelmark M, Smith RM, Szpirt WM, Tomasson G, Trivioli G, Vaglio A, Walsh M, Wester Trejo M, Westman K, Bajema IM, Jayne DR. The Sound of Interconnectivity; The European Vasculitis Society 2022 Report. Kidney International Reports 2022. [DOI: 10.1016/j.ekir.2022.05.018] [Reference Citation Analysis]
8 Hellmich B, Holle J, Moosig F. [Eosinophilic granulomatosis with polyangiitis : Update on classification and management]. Z Rheumatol 2022. [PMID: 35075511 DOI: 10.1007/s00393-021-01153-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Sepiashvili L, Kenyon SM. Clinical, Methodological, and Practical Considerations for Algorithmic Testing in Autoimmune Serology. J Appl Lab Med 2022;7:268-80. [PMID: 34996074 DOI: 10.1093/jalm/jfab121] [Reference Citation Analysis]
10 Mukherjee M, Nair P. Eosinophils as potential mediators of autoimmunity in eosinophilic lung disease. Eosinophilic Lung Diseases 2022. [DOI: 10.1183/2312508x.10030720] [Reference Citation Analysis]
11 Specks U. Vasculitis and Alveolar Hemorrhage. Encyclopedia of Respiratory Medicine 2022. [DOI: 10.1016/b978-0-08-102723-3.00070-6] [Reference Citation Analysis]
12 Vlasenko NV, Bulanov NM, Moiseev SV, Semenenko TA, Kuzin SN, Akimkin VG. Influence of Genetic Factors on Immunopathogenesis and Clinical Phenotypes of ANCA-associated Vasculitis. Annals RAMS 2021;76:642-651. [DOI: 10.15690/vramn1702] [Reference Citation Analysis]
13 Folci M, Ramponi G, Solitano V, Brunetta E. Serum ANCA as Disease Biomarkers: Clinical Implications Beyond Vasculitis. Clin Rev Allergy Immunol 2021. [PMID: 34460071 DOI: 10.1007/s12016-021-08887-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Yang W, Zhou Z, Wu H, Liu C, Shen B, Ding S, Zhou Y. Multi-function PtCo nanozymes/CdS nanocrystals@graphene oxide luminophores and K2S2O8/H2O2 coreactants-based dual amplified electrochemiluminescence immunosensor for ultrasensitive detection of anti-myeloperoxidase antibody. J Nanobiotechnology 2021;19:225. [PMID: 34325706 DOI: 10.1186/s12951-021-00968-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
15 Kotas ME, Dion J, Van Dyken S, Ricardo-Gonzalez RR, Danel CJ, Taillé C, Mouthon L, Locksley RM, Terrier B. A role for IL-33-activated ILC2s in eosinophilic vasculitis. JCI Insight 2021;6:143366. [PMID: 33974563 DOI: 10.1172/jci.insight.143366] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
16 Damoiseaux J. ANCA Testing in Clinical Practice: From Implementation to Quality Control and Harmonization. Front Immunol 2021;12:656796. [PMID: 33796118 DOI: 10.3389/fimmu.2021.656796] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Fagni F, Bello F, Emmi G. Eosinophilic Granulomatosis With Polyangiitis: Dissecting the Pathophysiology. Front Med (Lausanne) 2021;8:627776. [PMID: 33718405 DOI: 10.3389/fmed.2021.627776] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 15.0] [Reference Citation Analysis]
18 Springer JM, Kalot MA, Husainat NM, Byram KW, Dua AB, James KE, Chang Lin Y, Turgunbaev M, Villa-Forte A, Abril A, Langford CA, Maz M, Chung SA, Mustafa RA. Eosinophilic Granulomatosis with Polyangiitis: A Systematic Review and Meta-Analysis of Test Accuracy and Benefits and Harms of Common Treatments. ACR Open Rheumatol 2021;3:101-10. [PMID: 33512787 DOI: 10.1002/acr2.11194] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]